Marianna Galliani
Overview
Explore the profile of Marianna Galliani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
77
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Galliani M, Signore G
Chempluschem
. 2020 Jan;
84(11):1653-1658.
PMID: 31943880
Photodynamic therapy (PDT) is an approach to treating cancer and involves light-induced activation of a photosensitizer that triggers the formation of reactive oxygen species (ROS) in targeted cells and subsequent...
2.
Del Grosso A, Galliani M, Angella L, Santi M, Tonazzini I, Parlanti G, et al.
Sci Adv
. 2019 Dec;
5(11):eaax7462.
PMID: 31799395
Lysosomal storage disorders (LSDs) result from an enzyme deficiency within lysosomes. The systemic administration of the missing enzyme, however, is not effective in the case of LSDs with central nervous...
3.
Galliani M, Tremolanti C, Signore G
Nanomaterials (Basel)
. 2019 Apr;
9(4).
PMID: 31018628
Therapeutic proteins and enzymes are a group of interesting candidates for the treatment of numerous diseases, but they often require a carrier to avoid degradation and rapid clearance in vivo....
4.
Galliani M, Santi M, Del Grosso A, Cecchettini A, Santorelli F, Hofmann S, et al.
Bioconjug Chem
. 2018 Jun;
29(7):2225-2231.
PMID: 29894633
Polymeric nanoparticles (NPs) represent one of the most promising tools in nanomedicine and have been extensively studied for the delivery of water-insoluble drugs. However, the efficient loading of therapeutic enzymes...
5.
Vilella A, Ruozi B, Belletti D, Pederzoli F, Galliani M, Semeghini V, et al.
Pharmaceutics
. 2015 Jun;
7(2):74-89.
PMID: 26102358
The success of nanomedicine as a new strategy for drug delivery and targeting prompted the interest in developing approaches toward basic and clinical neuroscience. Despite enormous advances on brain research,...